EFFECT OF SUPPLEMENTAL CARBIDOPA ON BIOAVAILABILITY OF L-DOPA

被引：40

作者：

CEDARBAUM, JM ^{[1
]}

KUTT, H ^{[1
]}

DHAR, AK ^{[1
]}

WATKINS, S ^{[1
]}

MCDOWELL, FH ^{[1
]}

机构：

[1] CORNELL UNIV,COLL MED,WHITE PLAINS,NY 10605

来源：

CLINICAL NEUROPHARMACOLOGY | 1986年 / 9卷 / 02期

关键词：

D O I：

10.1097/00002826-198604000-00006

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：153 / 159

页数：7

共 24 条

[1]

ANDERSSON I, 1975, ACTA MED SCAND, V198, P415

[2] VALIDITY AND RELIABILITY OF A RATING-SCALE FOR THE PRIMARY TORSION DYSTONIAS [J].

BURKE, RE ;

FAHN, S ;

MARSDEN, CD ;

BRESSMAN, SB ;

MOSKOWITZ, C ;

FRIEDMAN, J .

NEUROLOGY, 1985, 35 (01) :73-77

[3] METHYLDOPAHYDRAZINE AS AN ADJUNCT TO L-DOPA THERAPY IN PARKINSONISM [J].

CHASE, TN ;

WATANABE, AM .

NEUROLOGY, 1972, 22 (04) :384-&

[4]

CURZON G, 1973, LANCET, V1, P781

[5]

ECKSTEIN B, 1973, LANCET, V1, P431

[6] INTESTINAL DECARBOXYLATION OF L-DOPA IN RELATION TO DOSE REQUIREMENT IN PARKINSONS-DISEASE [J].

GRANERUS, AK ;

JAGENBURG, R ;

SVANBORG, A .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 280 (04) :429-439

[7] ENZYMES RELATED TO MONOAMINE TRANSMITTER METABOLISM IN BRAIN MICRO-VESSELS [J].

HARDEBO, JE ;

EMSON, PC ;

FALCK, B ;

OWMAN, C ;

ROSENGREN, E .

JOURNAL OF NEUROCHEMISTRY, 1980, 35 (06) :1388-1393

[8] ON-OFF FLUCTUATIONS IN PARKINSONS-DISEASE - A CLINICAL AND NEURO-PHARMACOLOGICAL STUDY [J].

HARDIE, RJ ;

LEES, AJ ;

STERN, GM .

BRAIN, 1984, 107 (JUN) :487-506

[9] CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN THE TREATMENT OF PARKINSONISM [J].

HUTTON, JT ;

DIPPEL, RL ;

BIANCHINE, JR ;

STRAHLENDORF, HK ;

MEYER, PG .

CLINICAL NEUROPHARMACOLOGY, 1984, 7 (02) :135-139

[10]

Jaffe ME, 1973, ADV NEUROL, V2, P161

← 1 2 3 →